Zolgensma Drug Interactions
Currently displaying a list of 34 drugs known to interact with Zolgensma (onasemnogene abeparvovec).
- 7 major drug interactions
- 27 moderate drug interactions
Medications known to interact with Zolgensma
Note: Showing generic names only.
- ashwaganda
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- bedaquiline
- black cohosh
- brentuximab
- calaspargase pegol
- cannabidiol
- clofarabine
- daclizumab
- efavirenz
- epirubicin
- etranacogene dezaparvovec
- fidanacogene elaparvovec
- idelalisib
- interferon beta-1a
- interferon beta-1b
- isoniazid
- ketoconazole
- leflunomide
- levoketoconazole
- lomitapide
- methotrexate
- mipomersen
- naltrexone
- pegaspargase
- peginterferon beta-1a
- pexidartinib
- remdesivir
- rifampin
- teriflunomide
- thioguanine
- trabectedin
- valoctocogene roxaparvovec
Zolgensma disease interactions
There are 3 disease interactions with Zolgensma (onasemnogene abeparvovec) which include:
More about Zolgensma (onasemnogene abeparvovec)
- Zolgensma consumer information
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous uncategorized agents
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Spinraza
Spinraza is used to treat spinal muscular atrophy (SMA) in children and adults. It is administered ...
Evrysdi
Evrysdi is used to treat spinal muscular atrophy (SMA) in adults, children, and infants. It is ...
Nusinersen
Nusinersen is an intrathecal injection used to treat spinal muscular atrophy (SMA) in children and ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.